common.study.topics.clinical

Testing Experimental Medication in Healthy Subjects

common.study.values.description

A Study of a Single Subcutaneous Dose of JNJ-26366821 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of a single subcutaneous (SC) dose of JNJ-26366821.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - JNJ-26366821

Participants will receive sterile solution of JNJ-26366821 subcutaneously (SC).

Drug - Placebo

Participants will receive sodium chloride injection as placebo on Day 1.

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Randomized, Placebo-Controlled, Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of a Single Subcutaneous Dose of JNJ-26366821 in Healthy Volunteers

common.study.values.clinical-trial-id

NCT03990519

participant.views.study.view.id

b82r3e